47.41
前日終値:
$47.49
開ける:
$47.52
24時間の取引高:
1.33M
Relative Volume:
0.60
時価総額:
$3.64B
収益:
-
当期純損益:
$-275.16M
株価収益率:
-12.19
EPS:
-3.89
ネットキャッシュフロー:
$-221.15M
1週間 パフォーマンス:
-4.97%
1か月 パフォーマンス:
-11.23%
6か月 パフォーマンス:
+46.87%
1年 パフォーマンス:
-3.68%
Springworks Therapeutics Inc Stock (SWTX) Company Profile
名前
Springworks Therapeutics Inc
セクター
電話
203-883-9490
住所
100 WASHINGTON BOULEVARD, STAMFORD, CT
SWTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
SWTX
Springworks Therapeutics Inc
|
47.41 | 3.64B | 0 | -275.16M | -221.15M | -3.89 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-11-20 | 開始されました | Evercore ISI | Outperform |
2024-02-05 | 開始されました | Guggenheim | Buy |
2022-12-01 | 開始されました | BofA Securities | Buy |
2021-01-19 | 繰り返されました | H.C. Wainwright | Buy |
2020-10-29 | 繰り返されました | H.C. Wainwright | Buy |
2020-05-05 | 開始されました | Barclays | Overweight |
2020-03-19 | アップグレード | H.C. Wainwright | Neutral → Buy |
2020-03-04 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2020-01-21 | 繰り返されました | H.C. Wainwright | Buy |
2019-12-04 | 開始されました | H.C. Wainwright | Buy |
2019-10-08 | 開始されました | Cowen | Outperform |
2019-10-08 | 開始されました | Goldman | Buy |
2019-10-08 | 開始されました | JP Morgan | Overweight |
2019-10-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Springworks Therapeutics Inc (SWTX) 最新ニュース
Cibc World Markets Corp Invests $232,000 in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Segall Bryant & Hamill LLC Purchases 58,522 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
BIT Capital GmbH Buys 8,429 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 2.5%Here's Why - MarketBeat
SpringWorks Therapeutics Target of Unusually Large Options Trading (NASDAQ:SWTX) - MarketBeat
Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Recursion Pharma, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics - Barchart
Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, - openPR
Raymond James Financial Inc. Invests $10.53 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
46,895 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Platinum Investment Management Ltd. - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 4.8%Should You Sell? - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Short Interest Update - MarketBeat
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
FDA’s new and supplemental approvals in February - BioCentury
Bank of New York Mellon Corp Sells 30,986 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
This Is What Whales Are Betting On SpringWorks Therapeutics - Benzinga
SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Te - GuruFocus.com
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Victory Capital Management Inc. - MarketBeat
High Growth Tech Stocks In The US Market March 2025 - Simply Wall St
How To Trade (SWTX) - Stock Traders Daily
SpringWorks Therapeutics Inc (SWTX) Q4 2024 Earnings Report Prev - GuruFocus.com
SpringWorks Shares Rise More Than 30% in 3 Months: Here's Why - TradingView
SpringWorks Therapeutics, Inc.'s (NASDAQ:SWTX) Shares Climb 26% But Its Business Is Yet to Catch Up - Simply Wall St
Victory Capital Management Inc. Reduces Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
SpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A Buzz - Seeking Alpha
Candriam S.C.A. Cuts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Traders Buy Large Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) CEO Saqib Islam Sells 49,000 Shares - MarketBeat
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest? - MSN
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) COO Badreddin Edris Sells 20,000 Shares - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 6%Should You Sell? - MarketBeat
SpringWorks gains after cancelling from investor conference - MSN
Check Out What Whales Are Doing With SWTX - Benzinga
SpringWorks Therapeutics Sees Unusually High Options Volume (NASDAQ:SWTX) - Defense World
Merck KGaA reports YE24 earnings growth amid SpringWorks acquisition talks - Yahoo
SpringWorks Therapeutics COO sells $1.08 million in common stock By Investing.com - Investing.com South Africa
SpringWorks Therapeutics CEO sells $2.66 million in stock By Investing.com - Investing.com South Africa
Springworks Therapeutics Inc (SWTX) 財務データ
収益
当期純利益
現金流量
EPS
Springworks Therapeutics Inc (SWTX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Islam Saqib | Chief Executive Officer |
Mar 03 '25 |
Sale |
54.24 |
49,000 |
2,657,656 |
954,869 |
Islam Saqib | Chief Executive Officer |
Feb 20 '25 |
Sale |
60.30 |
29,328 |
1,768,401 |
1,034,625 |
Ashar Bhavesh | Chief Commercial Officer |
Feb 20 '25 |
Sale |
61.19 |
1,016 |
62,168 |
62,053 |
LYNCH DANIEL | Director |
Feb 20 '25 |
Sale |
60.22 |
47,600 |
2,866,534 |
82,944 |
大文字化:
|
ボリューム (24 時間):